Treatment of dogs with Bravecto® (fluralaner) reduces mosquito survival and fecundity

Author:

Evans Christopher Charles1,Normile Dorothy2,Gamble Sheryl2,Guerino Frank2,Dzimianski Michael T.1,Moorhead Andrew Riddell1

Affiliation:

1. University of Georgia

2. Merck Animal Health

Abstract

Abstract Background: Mosquitoes serve as the vector of canine heartworm (Dirofilaria immitis), which represents a significant and persistent threat to canine health. A reduction in the longevity and/or reproductive success of mosquitoes that take a bloodmeal from fluralaner-treated dogs may consequently reduce the local transmission of heartworm and prevent new infections. This study investigated a novel secondary effect of an oral formulation of the ectoparasiticide fluralaner (Bravecto®) against a laboratory strain of mosquito (Aedes aegypti). Methods: Six dogs were administered a single dose of fluralaner orally in the form of Bravecto® Chews (at the labeled fluralaner dose of 25 mg/kg body weight) while six control dogs received no treatment. Mosquitoes were fed on blood collected from each dog; this was performed prior to treatment and weekly for 15 weeks posttreatment to assess the continued duration of effects as serum fluralaner levels decrease. Mosquito fitness was assessed by three parameters: rate of successful blood feeding, survival, and egg laying. Results: Blood feeding was equally successful between control and treatment groups. Fluralaner treatment significantly reduced mosquito survival within the first day of blood feeding for 12 weeks posttreatment (efficacy range = 33.2% – 73.3%). Survival of mosquitoes to a potentially heartworm-infective timepoint (14 days postfeeding) was significantly reduced in the fluralaner-treated group at several timepoints, but less consistently (weeks 1, 2, 5, 11, 12, 13, 14, and 15; efficacy range = 49.4% – 91.4%). Egg laying by mosquitoes was almost completely suppressed for the first 13 weeks following treatment (treatment efficacy = 100%). Conclusions: Mosquitoes fed blood from fluralaner-treated dogs experienced a significant reduction in survival and fecundity. These findings support the potential for reduction in heartworm transmission directly by lethal effects on the vector and indirectly by reduction of the local vector population when mosquitoes are exposed to treated animals.

Publisher

Research Square Platform LLC

Reference27 articles.

1. Noack S, Harrington J, Carithers DS, Kaminsky R, Selzer PM. Heartworm disease – Overview, intervention, and industry perspective. Int J Parasitol Drugs Drug Resist. 2021;16:65–89. Available from: https://www.sciencedirect.com/science/article/pii/S2211320721000142

2. Human and animal dirofilariasis: the emergence of a zoonotic mosaic;Simon F;Clin Microbiol Rev. United States,2012

3. Genchi C, Kramer LH. The prevalence of Dirofilaria immitis and D. repens in the Old World. Vet Parasitol. Elsevier; 2020 [cited 2020 Mar 20];280:108995. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0304401719302766

4. It shouldn’t happen to a dog … or a veterinarian: clinical paradigms for canine vector-borne diseases;Irwin PJ;Trends Parasitol. England,2014

5. Genchi C, Bowman D, Drake J. Canine heartworm disease (Dirofilaria immitis) in Western Europe: survey of veterinary awareness and perceptions. Parasit Vectors. 2014;7:206. Available from: https://doi.org/10.1186/1756-3305-7-206

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3